102850-29-3

Usage

InChI:InChI=1/C6H16O18P4/c7-1-3(21-25(9,10)11)2(8)5(23-27(15,16)17)6(24-28(18,19)20)4(1)22-26(12,13)14/h1-8H,(H2,9,10,11)(H2,12,13,14)(H2,15,16,17)(H2,18,19,20)/t1-,2-,3?,4-,5+,6?/m0/s1

Upstream product

• 98510-20-4 myo-Inositol orthoformate 
• 114828-05-6 4/6-O-allyl-myo-inositol 1,3 5-monoorthoformate 
• 114828-06-7 (+/-) 2,6-di-O-benzyl-4-O-allyl-myo-inositol orthoformate 
• 115133-07-8 (1R,5S,6S,7R,8S,9R)-6,8-Bis-benzyloxy-9-benzyloxymethoxy-2,4,10-trioxa-tricyclo[3.3.1.1^3,7]decane 
• 16749-97-6 racemic 2,4-di-O-benzyl-myo-inositol 
• 114342-99-3 (+/-) 2,6-di-O-benzyl-myo-inositol 1,3,4,5-tetrakis(dibenzylphosphate) 
• 126960-08-5 C₅₂H₅₂O₁₈P₄ 

Relevant academic research and scientific papers

The Total Synthesis of myo-Inositol Phosphates via myo-Inositol Orthoformate

Novel selective alkylations of myo-inositol orthoformate (4) have been used to prepare a series of protected myo-inositol derivatives, (5a-e), (7), (10), (12), and (16).These intermediates have been used in efficient total syntheses of myo-inositol 2-phosphate, (9); myo-inositol 4-phosphate, (6); myo-inositol 1,3-bisphosphate, (18); and myo-inositol 1,3,4,5-tetrakisphosphate (14).This report represents the first total synthesis of the important natural metabolites (14) and (18) and significantly improved methods of preparation of (6) and (9).